We want this website to meet your needs as best as possible. To this end, we use the web analytics tool Matomo to learn which pages are visited most often. Your visit is currently not being counted.
By allowing us to count your visit anonymously, you help us to achieve this goal. Web analytics enable us to adapt this website to your needs. No data is forwarded to third parties. Your decision is stored in a so-called consent cookie on your hard drive. The consent cookie is automatically deleted after 24 hours. For further information, please see our privacy notice.
German-Israeli cooperation in the life sciences can look back on almost 50 years of successful joint projects. Cooperation in cancer research (DKFZ) is of great importance. Israel is an important cooperation partner for the Helmholtz Association’s other centres in the field of health research, including artificial intelligence. Cooperation is increasingly taking place in transnational initiatives, for example in ERA networks.
The cooperation between the Federal Ministry of Education and Research (BMBF) and the Ministry of Innovation, Science and Technology (MOST) in cancer research began in 1976 and is implemented by the German Cancer Research Centre (DKFZ) in Heidelberg and Israeli research institutions and universities. Research focuses, inter alia, on cell and tumour biology, functional and structural genome research, tumour immunology, infection and cancer as well as on translational cancer research and personalised medicine.
Germany and Israel also cooperate closely in other areas of the life sciences (e.g. neurosciences, biotechnology and medical technology). The current cooperation between BioNTech and the Weizmann Institute of Science (WIS) is emblematic of this. Minerva Centers have been established at several Israeli research institutions in various fields of the life sciences.
